Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 12, 2026
A major shareholder of Avalyn Pharma sold $1.45M of Avalyn Pharma shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,450,079
Shares × reported transaction price
90 days after results of Aug 12, 2026, 2 days before results of Nov 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 2 days before AVLN reported its results (Nov 12, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Fund moves
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 9 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Avalyn Pharma sold $40K of Avalyn Pharma shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 10 · filed 2 days laterNot reported under a pre-arranged trading plan
A major shareholder of Avalyn Pharma sold $165K of Avalyn Pharma shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.